Alegre, John Mark Y.

HRN: 28-69-98  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/17/2026
CEFUROXIME 750MG (VIAL)
03/17/2026
03/24/2026
IV
420mg
Q8
AGE URTI
Checking Initial Appropriateness 
03/20/2026
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
03/20/2026
03/27/2026
IV
5ml
TID
Intestinal Amoebasis
Checking Initial Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: